Drawing for VASCUDYNE

USPTO serial 98297501

VASCUDYNE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HAYNES, SAMANTHA M
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with VASCUDYNE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DYAN M. HOUSE

DYAN M. HOUSE BAKER & MCKENZIE, LLP1900 N. PEARL STREETSUITE 1500DALLAS, TX 75201

Goods and services

ClassDescriptionStatusFirst use
005Cardiovascular agents for medical purposes for the treatment of cardiac disease and related cardiac conditions; pharmaceutical preparations for use in treating cardiac disease and related cardiac conditionsABANDONED—
010Surgical apparatus and instruments; surgical apparatus for medical, dental or veterinary use; medical and surgical apparatus and instruments, namely, implantable artificial cardiac valves; medical and surgical implants made of artificial materials; medical apparatus and instruments for use in percutaneous and endovascular procedures; medical device for treating cardiac conditions consisting of a delivery system for artificial cardiac valves; medical apparatus and instruments for use in cardiovascular procedures; medical apparatus and instruments for treating cardiovascular disease; cardiac valves for surgical prostheses; prostheses for cardiovascular systems, namely, for the heart and heart valves; artificial cardiac valves for implantation as part of the cardiovascular system; subcutaneous valves comprised of artificial materials for implantation as part of the cardiovascular system; artificial cardiac valve implants consisting of artificial materials for implementation as part of the cardiovascular system; medical devices for use in treating cardiac disease; artificial cardiac valves in the nature of replacement tissue valves comprising artificial and natural, non-living materials for the human heart; catheters; medical stentsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2025MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Nov 12, 2025ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Nov 12, 2025OP.TOPPOSITION TERMINATED NO. 999999—
Nov 12, 2025OP.SOPPOSITION SUSTAINED NO. 999999—
Mar 12, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Mar 11, 2025OP.IOPPOSITION INSTITUTED NO. 999999—
Dec 12, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2024DOCKASSIGNED TO EXAMINER—
Feb 27, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance